What Are the IRB's Obligations to Review the Use of Drugs for Purposes That FDA Has Not Approved?

&
IRB: Ethics & Human Research 4 (4):8 (1982)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.2307/3564378

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,923

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Prescribing Approved Drugs for Nonapproved Uses: Physicians' Disclosure Obligations to Their Patients.Marshall B. Kapp - 1981 - Journal of Law, Medicine and Ethics 9 (6):20-23.
Prescribing Approved Drugs for Nonapproved Uses: Physicians' Disclosure Obligations to Their Patients.Marshall B. Kapp - 1981 - Journal of Law, Medicine and Ethics 9 (6):20-23.
Approval and Withdrawal of New Antibiotics and Other Antiinfectives in the U.S., 1980–2009.Kevin Outterson, John H. Powers, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio & Aaron S. Kesselheim - 2013 - Journal of Law, Medicine and Ethics 41 (3):688-696.
What If Fiduciary Obligations Are Like Contractual Ones?Gregory Klass - unknown
[Book review] drugs and rights. [REVIEW]Douglas N. Husak - 1995 - Criminal Justice Ethics 14 (1):63-72.
Off-Label Drug Use as a Consent and Health Regulation Issue in New Zealand.Rebecca Julia Cook - 2015 - Journal of Bioethical Inquiry 12 (2):251-258.
Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):654-664.
Recent Developments in Health Law: FDA and Drug Safety: New Tufts Study Challenges Critics of the Prescription Drug User Fee Act.Rochelle Lee - 2006 - Journal of Law, Medicine and Ethics 34 (1):131-134.
Deploying the Precautionary Principle to Protect Vulnerable Populations in Canadian Post-Market Drug Surveillance.Maxwell Smith, Ana Komparic & Alison Thompson - 2020 - Canadian Journal of Bioethics / Revue canadienne de bioéthique 3 (1):110-118.
Ethical Issues in New Drug Prescribing.Lindsay W. Cole, Jennifer C. Kesselheim & Aaron S. Kesselheim - 2012 - Journal of Bioethical Inquiry 9 (1):77-83.
Prescribing Approved Drugs for Nonapproved Uses: The Pharmacist's Potential for Liability.Gerald A. Mazzucca - 1981 - Journal of Law, Medicine and Ethics 9 (6):24-25.
Prescribing Approved Drugs for Nonapproved Uses: The Pharmacist's Potential for Liability.Gerald A. Mazzucca - 1981 - Journal of Law, Medicine and Ethics 9 (6):24-25.
Drugs and Rights.Douglas N. Husak - 1992 - Cambridge University Press.
Extortion and the Ethics of “Topping Up”.Benjamin Sachs - 2009 - Cambridge Quarterly of Healthcare Ethics 18 (4):443-445.
Prenatal Drug Use: Legal and Ethical Considerations and the Role of Health Providers in Addressing the Problem.Katherine Leigh Acuff - 1996 - Dissertation, The Johns Hopkins University

Analytics

Added to PP
2021-04-28

Downloads
7 (#1,409,222)

6 months
4 (#859,620)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references